Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)
China flag China · Delayed Price · Currency is CNY
17.38
+0.08 (0.46%)
Feb 3, 2026, 11:36 AM CST

SHE:002603 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
1,034853.03940.511,904995.261,337
Trading Asset Securities
910.5-205.97518.3855.27216.97
Cash & Short-Term Investments
1,945853.031,1462,4231,0511,554
Cash Growth
112.26%-25.60%-52.68%130.61%-32.40%51.44%
Accounts Receivable
1,7551,3902,5962,1782,3611,756
Other Receivables
18.97130.075.596.544.7318.27
Receivables
1,7741,5202,6022,1842,3661,775
Inventory
1,6851,7462,4592,0221,6731,580
Prepaid Expenses
-26.0993.90.739.3937.04
Other Current Assets
136.05189.28242.67624.8473.65513.54
Total Current Assets
5,5404,3356,5447,2545,6025,459
Property, Plant & Equipment
7,0167,2537,3116,2295,7584,313
Long-Term Investments
2.463.471,6511,34911
Goodwill
104.83109.51115.75---
Other Intangible Assets
785.32802.57743.52724.01660.5480.41
Long-Term Deferred Tax Assets
307.69365.84183.58284.43117137.77
Long-Term Deferred Charges
326.43266.88189.37107.16239.33261.17
Other Long-Term Assets
137.65183.39241.39392.65527.03839.62
Total Assets
14,22013,31916,97916,34112,90511,492
Accounts Payable
1,8061,8972,8472,0611,6211,188
Accrued Expenses
182.91350.83419.64644.78269.71306.97
Short-Term Debt
--600.35500.35702.48270.18
Current Portion of Long-Term Debt
--201.12150.12--
Current Portion of Leases
9.858.245.55.8613.43-
Current Income Taxes Payable
109.2823.4642.45242.1511.3859.4
Current Unearned Revenue
342.08272.34287.521,106301.56354.74
Other Current Liabilities
550.4355.2643.58140.3540.759.21
Total Current Liabilities
3,0012,6074,4474,8502,9602,239
Long-Term Debt
--599.1200.15500.47-
Long-Term Leases
20.4818.2113.0114.9712.53-
Long-Term Unearned Revenue
390.92377.92352.37335.02357.84328.09
Long-Term Deferred Tax Liabilities
110.68114.25130.1410.241.392.02
Total Liabilities
3,5233,1175,5415,4113,8332,569
Common Stock
1,6711,6711,6711,6711,6711,204
Additional Paid-In Capital
2,3242,3432,3432,3432,3432,932
Retained Earnings
6,7166,2177,4436,9265,0654,915
Treasury Stock
------122.15
Comprehensive Income & Other
-7.02-7.12-6.61-7.22-9.71-9.08
Total Common Equity
10,70410,22311,45010,9329,0698,919
Minority Interest
-6.19-21.4-11.73-1.953.044.09
Shareholders' Equity
10,69810,20211,43810,9309,0728,923
Total Liabilities & Equity
14,22013,31916,97916,34112,90511,492
Total Debt
30.3326.451,419871.451,229270.18
Net Cash (Debt)
1,915826.58-272.61,551-178.371,284
Net Cash Growth
-----31.52%
Net Cash Per Share
1.150.49-0.160.93-0.110.77
Filing Date Shares Outstanding
1,6711,6711,6711,6711,6711,667
Total Common Shares Outstanding
1,6711,6711,6711,6711,6711,667
Working Capital
2,5391,7282,0972,4042,6423,221
Book Value Per Share
6.416.126.856.545.435.35
Tangible Book Value
9,8149,31110,59010,2088,4098,439
Tangible Book Value Per Share
5.875.576.346.115.035.06
Buildings
-5,6685,4074,3533,6202,997
Machinery
-3,5813,0982,4842,0051,499
Construction In Progress
-1,1971,4711,5741,9501,371
Source: S&P Global Market Intelligence. Standard template. Financial Sources.